Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats
Main Author: | |
---|---|
Publication Date: | 2010 |
Other Authors: | , , , , |
Format: | Article |
Language: | por |
Source: | Repositório Institucional da UFRN |
Download full: | https://repositorio.ufrn.br/jspui/handle/123456789/25362 http://dx.doi.org/10.4172/1948-593X.1000021 |
Summary: | The purpose of this study was to determine naproxen concentrations in rat plasma samples by HPLC and to compare the bioavailability of a generic and two compounded naproxen sodium suspensions (test 1 and test 2). Analysis was run at a fl ow rate of 1.2 mL.min -1 with a mobile phase of acetonitrile: NaH 2 PO 4 0.01 M pH 4.00 (50:50, v/v) at 280 nm, using a C 18 column (150 mm x 4.6 mm, 5 μ m). The calibration curve was linear (R 2 = 0.9987) over the range of 0.25 - 200 μ g.mL -1 . The precision for inter and intra-day analysis ranged from 2.46% to 12.39%. C max , T max and AUC t were 191.25 ± 11.17 μ g.mL -1 , 1.00 ± 0.106 h and 2438.16 ± 291.34 μ g.h.mL -1 for the reference drug, 188.22 ± 24.78 μ g.mL -1 , 1.06 ± 0.092 h and 1755.02 ± 228.90 μ g.h.mL -1 for test 1, and 160.50 ± 10.58 μ g.mL -1 , 0.66 ± 0.102 h and 1955.28 ± 142.80 μ g.h.mL -1 for test 2. No signi fi cant differences were found based on analysis of variance, with mean values and 90% CI of test2/reference ratio (C max 83.92% and AUC t 80.19%). For test1/reference ratio, the result was C max 98.41% and AUC t 71.98%. Based on these results, it can be concluded that the validated method was successfully applied to this study; the test 1 formulation failed to demonstrate a bioequivalence to the reference drug; however, the test 2 and reference naproxen sodium suspension were bioequivalent in terms of the rate and extent of absorption under these conditions. |
id |
UFRN_37f7249ec5dedbddfba5b626d767326c |
---|---|
oai_identifier_str |
oai:https://repositorio.ufrn.br:123456789/25362 |
network_acronym_str |
UFRN |
network_name_str |
Repositório Institucional da UFRN |
repository_id_str |
|
spelling |
Araujo, Aurigena Antunes deSolon, Lílian Grace da SilvaGuerra, Gerlane Bernardo CoelhoBarichello, José MárioPérez-Urizar, JoséSoares, Luiz Alberto Lira2018-06-12T15:16:40Z2018-06-12T15:16:40Z2010-04-23ARAUJO, Aurigena Antunes de; et al. Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats. Journal of Bioanalysis & Biomedicine, v. 2, p. 48-54, 2010. Disponível em: < https://www.omicsonline.org/comparative-bioavailability-of-a-generic-and-two-compounded-naproxen-sodium-suspensions-administered-to-rats-1948-593X.1000021.php?aid=336> Acesso em: 13 mar. 2018.1948-593Xhttps://repositorio.ufrn.br/jspui/handle/123456789/25362http://dx.doi.org/10.4172/1948-593X.1000021porJ Bioanal BiomedBioavailability studiesValidationHPLCPharmacokineticsCompounded naproxen sodium suspensionComparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Ratsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleThe purpose of this study was to determine naproxen concentrations in rat plasma samples by HPLC and to compare the bioavailability of a generic and two compounded naproxen sodium suspensions (test 1 and test 2). Analysis was run at a fl ow rate of 1.2 mL.min -1 with a mobile phase of acetonitrile: NaH 2 PO 4 0.01 M pH 4.00 (50:50, v/v) at 280 nm, using a C 18 column (150 mm x 4.6 mm, 5 μ m). The calibration curve was linear (R 2 = 0.9987) over the range of 0.25 - 200 μ g.mL -1 . The precision for inter and intra-day analysis ranged from 2.46% to 12.39%. C max , T max and AUC t were 191.25 ± 11.17 μ g.mL -1 , 1.00 ± 0.106 h and 2438.16 ± 291.34 μ g.h.mL -1 for the reference drug, 188.22 ± 24.78 μ g.mL -1 , 1.06 ± 0.092 h and 1755.02 ± 228.90 μ g.h.mL -1 for test 1, and 160.50 ± 10.58 μ g.mL -1 , 0.66 ± 0.102 h and 1955.28 ± 142.80 μ g.h.mL -1 for test 2. No signi fi cant differences were found based on analysis of variance, with mean values and 90% CI of test2/reference ratio (C max 83.92% and AUC t 80.19%). For test1/reference ratio, the result was C max 98.41% and AUC t 71.98%. Based on these results, it can be concluded that the validated method was successfully applied to this study; the test 1 formulation failed to demonstrate a bioequivalence to the reference drug; however, the test 2 and reference naproxen sodium suspension were bioequivalent in terms of the rate and extent of absorption under these conditions.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRNinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNTEXTComparative Bioavailability of a Generic_2010.pdf.txtComparative Bioavailability of a Generic_2010.pdf.txtExtracted texttext/plain36439https://repositorio.ufrn.br/bitstream/123456789/25362/3/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.txt619d7943196bb58001bbb5de068b99ceMD53THUMBNAILComparative Bioavailability of a Generic_2010.pdf.jpgComparative Bioavailability of a Generic_2010.pdf.jpgIM Thumbnailimage/jpeg9391https://repositorio.ufrn.br/bitstream/123456789/25362/4/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.jpg8d428a87995c9d20e365b082e0ddea5fMD54TEXTComparative Bioavailability of a Generic_2010.pdf.txtComparative Bioavailability of a Generic_2010.pdf.txtExtracted texttext/plain36439https://repositorio.ufrn.br/bitstream/123456789/25362/3/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.txt619d7943196bb58001bbb5de068b99ceMD53THUMBNAILComparative Bioavailability of a Generic_2010.pdf.jpgComparative Bioavailability of a Generic_2010.pdf.jpgIM Thumbnailimage/jpeg9391https://repositorio.ufrn.br/bitstream/123456789/25362/4/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.jpg8d428a87995c9d20e365b082e0ddea5fMD54ORIGINALComparativeBioavailabilityGeneric_Araujo_2010.pdfComparativeBioavailabilityGeneric_Araujo_2010.pdfapplication/pdf1127861https://repositorio.ufrn.br/bitstream/123456789/25362/1/ComparativeBioavailabilityGeneric_Araujo_2010.pdff2a3f7cb6503a2508949583a898a1bc4MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.ufrn.br/bitstream/123456789/25362/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD52123456789/253622021-11-11 17:21:25.422oai:https://repositorio.ufrn.br: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Repositório de PublicaçõesPUBhttp://repositorio.ufrn.br/oai/opendoar:2021-11-11T20:21:25Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)false |
dc.title.pt_BR.fl_str_mv |
Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats |
title |
Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats |
spellingShingle |
Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats Araujo, Aurigena Antunes de Bioavailability studies Validation HPLC Pharmacokinetics Compounded naproxen sodium suspension |
title_short |
Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats |
title_full |
Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats |
title_fullStr |
Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats |
title_full_unstemmed |
Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats |
title_sort |
Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats |
author |
Araujo, Aurigena Antunes de |
author_facet |
Araujo, Aurigena Antunes de Solon, Lílian Grace da Silva Guerra, Gerlane Bernardo Coelho Barichello, José Mário Pérez-Urizar, José Soares, Luiz Alberto Lira |
author_role |
author |
author2 |
Solon, Lílian Grace da Silva Guerra, Gerlane Bernardo Coelho Barichello, José Mário Pérez-Urizar, José Soares, Luiz Alberto Lira |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Araujo, Aurigena Antunes de Solon, Lílian Grace da Silva Guerra, Gerlane Bernardo Coelho Barichello, José Mário Pérez-Urizar, José Soares, Luiz Alberto Lira |
dc.subject.por.fl_str_mv |
Bioavailability studies Validation HPLC Pharmacokinetics Compounded naproxen sodium suspension |
topic |
Bioavailability studies Validation HPLC Pharmacokinetics Compounded naproxen sodium suspension |
description |
The purpose of this study was to determine naproxen concentrations in rat plasma samples by HPLC and to compare the bioavailability of a generic and two compounded naproxen sodium suspensions (test 1 and test 2). Analysis was run at a fl ow rate of 1.2 mL.min -1 with a mobile phase of acetonitrile: NaH 2 PO 4 0.01 M pH 4.00 (50:50, v/v) at 280 nm, using a C 18 column (150 mm x 4.6 mm, 5 μ m). The calibration curve was linear (R 2 = 0.9987) over the range of 0.25 - 200 μ g.mL -1 . The precision for inter and intra-day analysis ranged from 2.46% to 12.39%. C max , T max and AUC t were 191.25 ± 11.17 μ g.mL -1 , 1.00 ± 0.106 h and 2438.16 ± 291.34 μ g.h.mL -1 for the reference drug, 188.22 ± 24.78 μ g.mL -1 , 1.06 ± 0.092 h and 1755.02 ± 228.90 μ g.h.mL -1 for test 1, and 160.50 ± 10.58 μ g.mL -1 , 0.66 ± 0.102 h and 1955.28 ± 142.80 μ g.h.mL -1 for test 2. No signi fi cant differences were found based on analysis of variance, with mean values and 90% CI of test2/reference ratio (C max 83.92% and AUC t 80.19%). For test1/reference ratio, the result was C max 98.41% and AUC t 71.98%. Based on these results, it can be concluded that the validated method was successfully applied to this study; the test 1 formulation failed to demonstrate a bioequivalence to the reference drug; however, the test 2 and reference naproxen sodium suspension were bioequivalent in terms of the rate and extent of absorption under these conditions. |
publishDate |
2010 |
dc.date.issued.fl_str_mv |
2010-04-23 |
dc.date.accessioned.fl_str_mv |
2018-06-12T15:16:40Z |
dc.date.available.fl_str_mv |
2018-06-12T15:16:40Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
ARAUJO, Aurigena Antunes de; et al. Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats. Journal of Bioanalysis & Biomedicine, v. 2, p. 48-54, 2010. Disponível em: < https://www.omicsonline.org/comparative-bioavailability-of-a-generic-and-two-compounded-naproxen-sodium-suspensions-administered-to-rats-1948-593X.1000021.php?aid=336> Acesso em: 13 mar. 2018. |
dc.identifier.uri.fl_str_mv |
https://repositorio.ufrn.br/jspui/handle/123456789/25362 |
dc.identifier.issn.none.fl_str_mv |
1948-593X |
dc.identifier.doi.none.fl_str_mv |
http://dx.doi.org/10.4172/1948-593X.1000021 |
identifier_str_mv |
ARAUJO, Aurigena Antunes de; et al. Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats. Journal of Bioanalysis & Biomedicine, v. 2, p. 48-54, 2010. Disponível em: < https://www.omicsonline.org/comparative-bioavailability-of-a-generic-and-two-compounded-naproxen-sodium-suspensions-administered-to-rats-1948-593X.1000021.php?aid=336> Acesso em: 13 mar. 2018. 1948-593X |
url |
https://repositorio.ufrn.br/jspui/handle/123456789/25362 http://dx.doi.org/10.4172/1948-593X.1000021 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
J Bioanal Biomed |
publisher.none.fl_str_mv |
J Bioanal Biomed |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRN instname:Universidade Federal do Rio Grande do Norte (UFRN) instacron:UFRN |
instname_str |
Universidade Federal do Rio Grande do Norte (UFRN) |
instacron_str |
UFRN |
institution |
UFRN |
reponame_str |
Repositório Institucional da UFRN |
collection |
Repositório Institucional da UFRN |
bitstream.url.fl_str_mv |
https://repositorio.ufrn.br/bitstream/123456789/25362/3/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.txt https://repositorio.ufrn.br/bitstream/123456789/25362/4/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.jpg https://repositorio.ufrn.br/bitstream/123456789/25362/3/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.txt https://repositorio.ufrn.br/bitstream/123456789/25362/4/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.jpg https://repositorio.ufrn.br/bitstream/123456789/25362/1/ComparativeBioavailabilityGeneric_Araujo_2010.pdf https://repositorio.ufrn.br/bitstream/123456789/25362/2/license.txt |
bitstream.checksum.fl_str_mv |
619d7943196bb58001bbb5de068b99ce 8d428a87995c9d20e365b082e0ddea5f 619d7943196bb58001bbb5de068b99ce 8d428a87995c9d20e365b082e0ddea5f f2a3f7cb6503a2508949583a898a1bc4 8a4605be74aa9ea9d79846c1fba20a33 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN) |
repository.mail.fl_str_mv |
|
_version_ |
1797777140925595648 |